Medical Bulletin 31/ August/ 2024 Dr. Garima Soni31 Aug 2024 3:00 PM ISTHere are the top medical news for the day:Why Men With Prostate Cancer At Higher Risk Of Alzheimer’s? Study UnravelsResearch published in the Journal...
Why Men With Prostate Cancer At Higher Risk Of Alzheimer's? Study Unravels Dr. Garima Soni31 Aug 2024 8:00 AM ISTResearch published in the Journal Science Advances indicates that prostate cancer treatment may increase the risk of developing Alzheimer's disease in...
Addition of ADT to radiation specially benefits black patients of prostate cancer:JAMA Dr Riya Dave14 Jun 2024 9:00 PM ISTResearchers have found that androgen-deprivation therapy (ADT) enhances the effectiveness of radiation therapy in Black men with localized prostate...
Relugolix Rapidly Achieves Sustained Castration in Prostate Cancer Patients Undergoing Radiotherapy: Study Dr Riya Dave3 April 2024 10:30 PM ISTProstate cancer remains one of the most prevalent cancers in men worldwide, often requiring a multimodal treatment approach for optimal management....
Medical Bulletin 03/July/2023 Isra Zaman3 July 2023 2:52 PM ISTHere are the top medical news for the day: Researchers identify unique cell receptor, potential for new therapiesResearchers from the University of...
AI Unlocks Prostate Cancer Treatment Benefits Isra Zaman3 July 2023 9:15 AM ISTData from a new study published in NEJM Evidence shows promise for personalized use of short-term ADT in men with predominantly intermediate-risk...
ADT increases risk of diabetes and hypertension in Prostate cancer patients but not metabolic syndrome Aditi30 Jan 2023 8:00 PM ISTUnited States: An original study published in Clinical Genitourinary cancer has concluded that in Prostate Cancer (PC) patients, Androgen Deprivation...
BDR Pharma launches generic APALUTAMIDE to treat Prostate cancer in India Ruchika Sharma3 Jan 2023 12:00 PM ISTApalutamide plus ADT (androgen-deprivation therapy) arm shows a significant decrease in the risk of disease progression and reduces risk of mortality...
Single-fraction stereotactic body radiotherapy promising for local prostate cancer recurrence Dr.Niharika Harsha B6 Dec 2022 7:30 PM ISTResearchers from Germany found that even in intensively pretreated prostate cancer patients single-fraction, PSMA-PET- and mpMRI-guided focal...
High dose Estetrol curbs hot flushes and improves QOl in prostate cancer patients on ADT Dr.Niharika Harsha B22 Nov 2022 8:00 PM ISTA new study found that high-dose fetal estrogen estetrol along with androgen deprivation therapy prevented the occurrence of hot flushes and improved...
Novartis gets positive EMA panel opinion for prostate cancer drug Pluvicto Ruchika Sharma17 Oct 2022 11:32 AM ISTPluvicto is a radioligand therapy combining a targeting compound (ligand, in this case directed to PSMA) with a therapeutic radioisotope
Orteronel fails to improve overall survival in metastatic prostate cancer: Study Dr. Hiral patel10 July 2022 8:00 PM ISTUSA: For patients with newly diagnosed metastatic hormone-sensitive prostate cancer, the addition of orteronel to androgen deprivation therapy (ADT)...
